Skip to main content
. 2018 Feb 8;7(4):e007341. doi: 10.1161/JAHA.117.007341

Table 2.

Results of Linear Mixed Models for Subjects in the Bi‐TENS Group Compared With Those in the Uni‐TENS Group From A0 to A2

Bi‐TENS Uni‐TENS Fixed Effects
Time Group Group‐By‐Time Interaction
Mean±SD Mean±SD Estimate; CI; P Value Estimate; CI; P Value Estimate; CI; P Value
Paretic ankle dorsiflexion strength, kg
 Wk 0 7.9±4.9 7.3±5.6 0.90;
0.22 to 1.59;
0.010a
−0.50;
−2.86 to 1.86;
0.675
1.32;
0.08 to 2.56;
0.032 a
 Wk 5 10.6±5.4 8.0±5.5
 Wk 10 12.4±6.5 9.2±6.9
Nonparetic ankle dorsiflexion strength, kg
 Wk 0 15.6±3.6 15.0±3.7 2.05;
1.33 to 2.78;
<0.001b
1.21;
−0.87 to 3.29;
0.249
−0.14;
−1.16 to 0.89;
0.790
 Wk 5 18.7±3.8 16.9±3.7
 Wk 10 19.4±5.0 19.1±4.3
Paretic ankle plantarflexion strength, kg
 Wk 0 12.6±5.7 11.9±5.4 0.99;
0.11 to 1.88;
0.029a
0.44;
−2.48 to 3.36;
0.766
0.65;
−0.97 to 2.26;
1.00
 Wk 5 14.5±6.2 11.9±5.6
 Wk 10 15.9±7.3 13.9±6.8
Nonparetic ankle plantarflexion strength, kg
 Wk 0 18.5±4.4 17.1±2.9 1.65;
0.68 to 2.64;
0.001
1.40;
−0.96 to 3.77;
0.241
0.085;
−1.30 to 1.47;
0.903
 Wk 5 19.9±4.0 18.1±4.2
 Wk 10 22.0±6.2 20.4±6.4
Paretic knee extension peak torque, Nm
 Wk 0 20.8±13.1 20.7±12.4 2.20
0.34 to 4.06;
0.021a
−0.46
−7.57 to 6.65;
0.898
1.48
−1.89 to 4.84;
1.00
 Wk 5 28.9±19.1 24.6±14.3
 Wk 10 28.2±15.4 25.1±15.8
Nonparetic knee extension peak torque, Nm
 Wk 0 44.9±20.6 41.4±12.6 1.98;
−0.54 to 4.49;
0.122
4.35;
−5.19 to 13.89;
0.371
−0.74;
−4.29 to 2.81;
0.682
 Wk 5 46.6±20.8 43.6±17.1
 Wk 10 47.4±19.6 45.4±13.1
Paretic knee flexion peak torque, Nm
 Wk 0 8.5±6.7 6.8±5.9 2.69;
1.33 to 4.04;
≤0.001b
1.48;
−2.19 to 5.16;
0.426
0.89;
−1.58 to 3.36;
1.000
 Wk 5 15.1±13.7 10.5±7.5
 Wk 10 15.6±12.6 12.2±8.2
Nonparetic knee flexion peak torque, Nm
 Wk 0 21.9±9.8 18.6±7.4 2.86;
1.38 to 4.34;
≤0.001b
1.94;
−2.94 to 6.82;
0.431
0.16;
−1.93 to 2.26;
0.878
 Wk 5 23.8±10.9 24.1±9.3
 Wk 10 28.0±12.7 24.3±7.5
LEMOCOT; paretic side
 Wk 0 12.9±12.4 10.8±7.7 2.08;
0.99 to 3.17;
≤0.001b
1.90;
−2.47 to 6.28;
0.389
−0.04;
−1.59 to 1.50;
0.955
 Wk 5 14.8±13.7 13.5±9.9
 Wk 10 17.0±15.1 15.0±12.2
LEMOCOT; nonparetic side
 Wk 0 36.1±11.2 33.8±7.3 3.56;
2.24 to 7.35;
≤0.001b
2.26;
−2.83 to 7.35;
0.379
−0.28;
−2.14 to 1.58;
0.763
 Wk 5 38.8±10.8 37.6±8.5
 Wk 10 42.6±10.3 40.9±9.3
Step test; paretic side
 Wk 0 7.5±3.7 7.3±3.4 0.96;
0.43 to 1.50;
0.001a
0.34;
−1.52 to 2.21;
0.716
0.02;
−0.74 to 0.78;
0.954
 Wk 5 8.6±3.7 8.0±2.7
 Wk 10 9.5±4.1 9.2±4.2
Step test; nonparetic side
 Wk 0 9.1±3.6 9.2±4.0 0.87;
0.15 to 1.60;
0.019a
0.07;
−2.16 to 2.29;
0.954
0.17;
−0.85 to 1.2;
0.745
 Wk 5 10.5±3.7 9.6±2.9
 Wk 10 11.2±4.3 10.9±4.9
BBS
 Wk 0 48.2±4.5 48.4±4.1 1.23;
0.69 to 1.78;
≤0.001b
0.08;
−2.25 to 2.4;
0.950
−0.18;
−0.94 to 0.59;
0.652
 Wk 5 49.8±3.6 49.9±3.9
 Wk 10 50.4±3.6 50.9±3.3
TUG, s
 Wk 0 19.2±8.3 19.2±8.0 −0.82;
−1.54 to −0.10;
0.026a
1.49;
−1.32 to 4.30;
0.485
−1.54;
−2.55 to −0.52;
0.004a
 Wk 5 17.2±7.6 18.8±8.0
 Wk 10 14.5±6.4 17.5±7.3

The CIs of interaction term of the primary outcomes were adjusted with Bonferroni correction; thus, 98.75% CIs were reported for the coefficient of interaction term of primary outcomes. 95% CIs were reported for rest of the coefficients. BBS indicates Berg Balance Scale; Bi‐TENS, bilateral transcutaneous electrical stimulation; CI, confidence interval; LEMOCOT, Lower Extremity Motor Coordination Test; TUG, Timed Up and Go Test; Uni‐TENS, unilateral transcutaneous electrical stimulation.

a

P≤0.05.

b

P≤0.001.